Boston Scientific will present data on key clinical programs at the 18th North American Neuromodulation Society (NANS) Meeting, being held in Las Vegas, from the 11-14 December 2014. The company’s data will focus on long-term back pain relief using the Boston Scientific Precision Spectra spinal cord stimulator system and highlight research on stimulation waveforms.
“We are excited about the continuing success of our next-generation Precision Spectra spinal cord stimulator system in providing sustained and highly significant low back pain relief, and we look forward to releasing our ’real-world’ experience with 12-month clinical data,” says Maulik Nanavaty, president, neuromodulation, Boston Scientific. “In addition, we are committed to further advancing the science and understanding of pain relief with our comprehensive research program exploring both high rate therapy and novel waveforms.”
Boston Scientific data will be presented during oral sessions or as posters. All programmes will be held at the Mandalay Bay and Four Seasons Hotels in Las Vegas. The programmes are as follows:
Precision Spectra spinal cord stimulation system:
- PRO study (low back pain) – One-year, multicentre consecutive case-series of patients with chronic low back pain treated with the Precision Spectra spinal cord stimulation system using a 32-contact multiple independent current control system.
Advanced Research Programs:
- ACCELERATE –Prospective multicentre trial evaluating high-rate (10 kHz) spinal cord stimulation in management of chronic, intractable pain.
- WHISPER – Prospective multicentre trial evaluating the use of sub-perception multiple independent current control spinal cord stimulation
- Preclinical Research – Pre-clinical model for investigating the mechanism of spinal cord stimulation.
Additionally, results will be released from the investigator-sponsored exploratory research of the sub-perception multiple independent current control spinal cord stimulation.